Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Adcock Ingram

02 2Amgen Inc

03 1Aprogen

04 54Celltrion

05 2Centocor

06 1Cipla Medpro South Africa

07 38Johnson & Johnson Innovative Medicine

08 54Organon

09 54Pfizer Consumer Healthcare

10 4Pfizer Inc

11 4Samsung Bioepis

12 2Sandoz B2B

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB-AXXQ

Brand Name : AVSOLA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/VIAL

Packaging :

Approval Date :

Application Number : 761086

Regulatory Info :

Registration Country : USA

blank

02

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

03

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB-DYYB

Brand Name : INFLECTRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 125544

Regulatory Info :

Registration Country : USA

blank

04

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB-DYYB

Brand Name : ZYMFENTRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG/ML

Packaging :

Approval Date :

Application Number : 761358

Regulatory Info :

Registration Country : USA

blank

05

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 26/08/2013

Application Number : 20120407000015

Regulatory Info : Approved

Registration Country : Sweden

blank

06

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Solution For Injection

Dosage Strength : 120mg

Packaging :

Approval Date : 22/11/2019

Application Number : 20181114000033

Regulatory Info : Approved

Registration Country : Sweden

blank

07

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Solution For Injection

Dosage Strength : 120mg

Packaging :

Approval Date : 22/11/2019

Application Number : 20181114000026

Regulatory Info : Approved

Registration Country : Sweden

blank

08

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 120MG

Packaging :

Approval Date : 2020-02-14

Application Number : 1130853012

Regulatory Info : Authorized

Registration Country : Spain

blank

09

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2015-03-24

Application Number : 13853001IP

Regulatory Info : Cancelled

Registration Country : Spain

blank

10

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2014-06-23

Application Number : 13853001

Regulatory Info : Authorized

Registration Country : Spain

blank

11

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2021-02-09

Application Number : 13853001IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

12

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB

Brand Name : REMICADE

Dosage Form : VIAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 103772

Regulatory Info :

Registration Country : USA

blank

13

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Remicade

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 13/08/1999

Application Number : 19990813000046

Regulatory Info : Approved

Registration Country : Sweden

blank

14

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB-QBTX

Brand Name : IXIFI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/VIAL

Packaging :

Approval Date :

Application Number : 761072

Regulatory Info :

Registration Country : USA

blank

15

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Inflectra

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 10/09/2013

Application Number : 20120825000017

Regulatory Info : Approved

Registration Country : Sweden

blank

16

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Inflectra

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2014-03-25

Application Number : 113854001

Regulatory Info : Authorized

Registration Country : Spain

blank

17

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

INFLIXIMAB-ABDA

Brand Name : RENFLEXIS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 761054

Regulatory Info :

Registration Country : USA

blank

18

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Flixabi

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 26/05/2016

Application Number : 20150305000183

Regulatory Info : Approved

Registration Country : Sweden

blank

19

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Zessly

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 18/05/2018

Application Number : 20170425000016

Regulatory Info : Approved

Registration Country : Sweden

blank

20

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Infliximab

Brand Name : Zessly

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 100MG

Packaging :

Approval Date : 2018-07-16

Application Number : 1181280001

Regulatory Info : Authorized

Registration Country : Spain

blank